Testing an investigational injection for moderate-to-severe asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new investigational medicine called EB070 given as an injection to see if it's safe and helps control asthma better than a placebo. It is for adults with moderate-to-severe asthma who are already taking daily controllers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate-to-severe asthma and have been diagnosed with asthma for at least 1 year.
- You are between 18 and 75 years old.
- Your lung function test shows that your airways open up by at least 12% when you use a rescue inhaler.
- You are using a daily inhaled corticosteroid (like Flovent, Pulmicort, Qvar) at a medium or high dose, and have been on the same dose for at least 3 months.
- You also use at least one other asthma controller medication, like a long-acting bronchodilator, Spiriva, or Singulair.
- You have not had a recent asthma attack requiring oral steroids, emergency room visit, or hospitalization in the last 8 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This trial tests a new drug called IBI3002 for people with moderate to severe asthma that isn't well controlled with standard inhalers. It aims to see if the drug is safe and tolerable when given multiple times.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This study tests an investigational medicine called WIN378, given as an injection, to see if it is safe and helps control moderate or severe asthma. It may be an option for people whose asthma is not well controlled with their current inhalers.
This trial tests an experimental drug called SHR-1905 for people with severe asthma that is not well controlled by their current treatments. The study aims to see if the drug can reduce asthma attacks and improve breathing.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.